Dutasteride Use in Women: Safety and Efficacy Considerations

Regulatory Status and Guidelines

• Clinical practice guidelines do not recommend dutasteride for women, as stated by guidelines from the American Society of Clinical Oncology and other organizations 1, 2
• The American Society of Clinical Oncology guidelines for breast cancer risk reduction do not include dutasteride as a recommended agent, instead recommending tamoxifen, raloxifene, or exemestane for women at high risk 3, 4
• Dutasteride is primarily indicated for benign prostatic hyperplasia in men, with its mechanism targeting male hormonal pathways, according to the American Urological Association 5